Contextualising cox-2 selective and non-selective NSAID risk - Providing a background for understanding risks of medical treatments

Contextualising cox-2 selective and non-selective NSAID risk - Providing a background for understanding risks of medical treatments

Détails bibliographiques
Auteurs principaux:	Moore, A, Derry, S
Format:	Conference item
Publié:	2006

Documents similaires

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs.
par: Moore, R, et autres
Publié: (2008)

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
par: Moore, R, et autres
Publié: (2008)

Calculating the balance of gastrointestinal and cardiovascular risk with combs and nsaids
par: Moore, A, et autres
Publié: (2006)

Comparison Between Two NSAIDs (Non selective & selective COX-2 Inhibitor) According to their Renal Toxicity on Elderly People
par: Haydar F. Hadi
Publié: (2007-06-01)

Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy
par: Marcella Goetz MORO, et autres

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
par: Riham M. Bokhtia, et autres
Publié: (2023-02-01)

Gastrointestinal harm from NSAIDs: An operations research approach
par: Moore, A, et autres
Publié: (2006)

Topical NSAIDs for chronic musculoskeletal pain in adults.
par: Derry, S, et autres
Publié: (2012)

Topical NSAIDs for chronic musculoskeletal pain in adults.
par: Derry, S, et autres
Publié: (2012)

Topical NSAIDs for acute pain in adults
par: Massey, T, et autres
Publié: (2010)

Topical NSAIDs for acute pain in adults.
par: Massey, T, et autres
Publié: (2010)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
par: Moore, R, et autres
Publié: (2006)

Topical NSAIDS for chronic musculoskeletal pain in adults
par: Derry, S, et autres
Publié: (2009)

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors
par: U Klotz
Publié: (2005-03-01)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
par: Alaa Rostom, et autres
Publié: (2009-10-01)

Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain
par: Christian Kirschneck, et autres
Publié: (2019-01-01)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
par: Phillips Ceri J, et autres
Publié: (2006-10-01)

Topical NSAIDs for acute pain: a meta-analysis
par: Mason, L, et autres
Publié: (2004)

NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies.
par: Luis Alberto García Rodríguez, et autres
Publié: (2011-02-01)

Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond
par: Praveen Rao, et autres
Publié: (2008-09-01)

Faecal blood loss: Systematic review and analysis of randomised trials with aspirin and NSAIDs
par: Moore, A, et autres
Publié: (2007)

Non-steroidal anti-inflammatory drugs(NSAIDs) and physiotherapy - a selective review
par: P. van der Bijl, et autres
Publié: (2002-01-01)

Examining the Risks for NSAID-Induced Gastropathy
par: Sherine E Gabriel, et autres
Publié: (1990-01-01)

Impact of NSAIDs on cardiovascular risk and hypertension
par: William B. White, et autres
Publié: (2013-03-01)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
par: Harris RE, et autres
Publié: (2012-08-01)

Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis
par: Filippo Migliorini, et autres
Publié: (2022-07-01)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
par: Straube, S, et autres
Publié: (2009)

Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment
par: Lixia Cheng, et autres
Publié: (2024-11-01)

Topical NSAIDs for acute pain: a meta-analysis
par: Derry Sheena, et autres
Publié: (2004-05-01)

Pharmacodynamic and Pharmacokinetic Comparison between Selective and Non-selective COX-2 Inhibitors in Mice
par: Taimaa Yahya, et autres
Publié: (2024-04-01)

Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2.
par: Haitao Li, et autres
Publié: (2013-01-01)

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
par: Moore, R, et autres
Publié: (2007)

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures
par: Čeponytė U, et autres
Publié: (2018-06-01)

COX ARCHITECTS : Selected and Current Works /
par: Dobney, Stephen, editor 208043, et autres
Publié: (1994)

Hartman-Cox : selected and current works /
par: 238867 Hartman, George E., et autres
Publié: (1994)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
par: Derry Sheena, et autres
Publié: (2009-06-01)

The Flux of Select NSAIDs through Silicone Membranes from Mineral Oil
par: Paul S. Mertz, et autres
Publié: (2014-07-01)

Cardiovascular risk of NSAIDs: time to translate knowledge into practice.
par: K Srinath Reddy, et autres
Publié: (2013-01-01)

Do NSAID/COX-2 Inhibitors Increase Nonunion After Fracture Surgery? Dilemma and Consideration In Use
par: Azmi
Publié: (2022-10-01)

Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs
par: Nada H. El-Dershaby, et autres
Publié: (2022-09-01)